Insulin Degludec and Symptomatic Nocturnal Hypoglycaemia

PHASE4CompletedINTERVENTIONAL
Enrollment

149

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

February 28, 2019

Study Completion Date

February 28, 2019

Conditions
Type 1 Diabetes MellitusNocturnal HypoglycemiaRecurrent Severe Hypoglycaemia
Interventions
DRUG

Insulin aspart/glargine

DRUG

Insulin aspart/degludec

Trial Locations (1)

3400

Nordsjaellands Hospital, Hilleroed

All Listed Sponsors
collaborator

Steno Diabetes Center Copenhagen

OTHER

collaborator

Hvidovre University Hospital

OTHER

collaborator

Copenhagen University Hospital, Denmark

OTHER

collaborator

Zealand University Hospital

OTHER

collaborator

Odense University Hospital

OTHER

collaborator

Aarhus University Hospital

OTHER

collaborator

Esbjerg Hospital - University Hospital of Southern Denmark

OTHER

lead

Nordsjaellands Hospital

OTHER

NCT02192450 - Insulin Degludec and Symptomatic Nocturnal Hypoglycaemia | Biotech Hunter | Biotech Hunter